Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape?
about
Sézary Syndrome and Atopic Dermatitis: Comparison of Immunological Aspects and TargetsLessons learned from gene expression profiling of cutaneous T-cell lymphomaPaucity of intraepidermal FoxP3-positive T cells in cutaneous T-cell lymphoma in contrast with spongiotic and lichenoid dermatitis.Functional polymorphisms of FAS and FASL gene and risk of breast cancer - pilot study of 134 cases.Fas ligand and the fate of antitumour cytotoxic T lymphocytes.Evolving insights in the pathogenesis and therapy of cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome)Density of neoplastic lymphoid infiltrate, CD8+ T cells, and CD1a+ dendritic cells in mycosis fungoides.Tumor-infiltrating immune cells promoting tumor invasion and metastasis: existing theories.Bacterial toxins fuel disease progression in cutaneous T-cell lymphoma.Increased Twist expression in advanced stage of mycosis fungoides and Sézary syndromePhase II Investigator-Initiated Study of Brentuximab Vedotin in Mycosis Fungoides and Sézary Syndrome With Variable CD30 Expression Level: A Multi-Institution Collaborative Project.Malignant inflammation in cutaneous T-cell lymphoma-a hostile takeover
P2860
Q26746551-8693141F-D4F3-4959-A8BA-B6ACB8EE1CCCQ26865858-64CB57D7-8730-4F38-9AA0-1D6232211FDCQ33835381-2A645CAB-7F3B-42F6-9C38-1A4444F44F54Q34551169-4613C01B-7C92-4DD9-9DBE-6A070CCFF7B5Q34579773-7016F828-C855-4C96-ABD2-19F3B44A8ADCQ35022833-A9D725DE-3A83-4651-919C-C647A858B7B2Q35586796-EA7195FF-F1B7-4EF4-8006-32F65F2221E5Q36587186-024591BE-B288-4BF5-B283-F996E4636275Q37139517-25836B58-E0E6-479B-8375-CC19B4657178Q37230256-3FD9A18B-B0AD-4CD5-A3AD-99E6C88712A5Q37384289-3A11CE64-BB46-42FE-993C-E8E74CD3BC68Q37723390-C2F809D0-4845-4E54-84DB-1D1C9E38D83C
P2860
Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape?
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Fas ligand expression by neopl ...... hanism of tumor immune escape?
@en
Fas ligand expression by neopl ...... hanism of tumor immune escape?
@nl
type
label
Fas ligand expression by neopl ...... hanism of tumor immune escape?
@en
Fas ligand expression by neopl ...... hanism of tumor immune escape?
@nl
prefLabel
Fas ligand expression by neopl ...... hanism of tumor immune escape?
@en
Fas ligand expression by neopl ...... hanism of tumor immune escape?
@nl
P2093
P1476
Fas ligand expression by neopl ...... hanism of tumor immune escape?
@en
P2093
P304
P407
P577
2001-09-01T00:00:00Z